High Content Screening Assay of Inhibitors of the Legionella Pneumophila Histone Methyltransferase RomA in Infected Cells
ChemBioChem · 2024
DOI: 10.1002/cbic.202400293 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2024. Verfasst von Magdalena Barbachowska und 8 weiteren Autor:innen. Beteiligte Einrichtung: Epigenetic Chemical Biology, Department of Structural Biology and Chemistry, Institut Pasteur, Université Paris Cité, CNRS UMR n°3523 Chem4Life, F-75…. Hauptthemen laut MEDLINE: Legionella pneumophila, Enzyme Inhibitors, Histone Methyltransferases. Die Arbeit nennt 46 Literaturangaben. Gefördert von: "Fondation de la Recherche Médicale", French Government.
Abstract (Originalsprache)
Resistance to anti‐microbial agents is a world‐wide health threat. Thus, there is an urgent need for new treatments. An alternative approach to disarm pathogens consists in developing drugs targeting epigenetic modifiers. Bacterial pathogens can manipulate epigenetic regulatory systems of the host to bypass defences to proliferate and survive. One example is Legionella pneumophila , a Gram‐negative intracellular pathogen that targets host chromatin with a specific, secreted bacterial SET‐domain methyltransferase named RomA. This histone methyltransferase specifically methylates H3 K14 during infection and is responsible for changing the host epigenetic landscape upon L. pneumophila infection. To inhibit RomA activity during infection, we developed a reliable high‐content imaging screening assay, which we used to screen an in‐house chemical library developed to inhibit DNA and histone methyltransferases. This assay was optimised using monocytic leukemic THP‐1 cells differentiated into macrophages infected with L. pneumophila in a 96‐ or 384‐well plate format using the Opera Phenix (Perkin Elmer) confocal microscope, combined with Columbus software for automated image acquisition and analysis. H3 K14 methylation was followed in infected, single cells and cytotoxicity was assessed in parallel. A first pilot screening of 477 compounds identified a potential starting point for inhibitors of H3 K14 methylation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Epigenetic Chemical Biology, Department of Structural Biology and Chemistry, Institut Pasteur, Université Paris Cité, CNRS UMR n°3523 Chem4Life, F-75015, Paris, France.
- Université Paris Cité, Ecole Doctorale MTCI, Paris, 75006, France.
- Pasteur-Paris University (PPU), Oxford International Doctoral program, Institut Pasteur, F-75015, Paris, France.
- Biology of Intracellular Bacteria, Department of Microbiology, Institut Pasteur, Université Paris Cité, F-75015, Paris, France.
- UtechS PBI - C2RT, Institut Pasteur, Université Paris Cité, F-75015, Paris, France.
- Chemogenomic and Biological Screening Core Facility - C2RT, Institut Pasteur, Université Paris Cité, F-75015, Paris, France.
ORCID-Profile: Jeanne Chiaravalli, Carmen Buchrieser, Monica Rolando, Paola B Arimondo
Förderung
- "Fondation de la Recherche Médicale"
- French Government
Zitieren
APA
Barbachowska, M., Harivel, T., Nicchi, S., Danckaert, A., Ghazarian, M., Chiaravalli, J., Buchrieser, C., Rolando, M., & Arimondo, P. B. (2024). High Content Screening Assay of Inhibitors of the Legionella Pneumophila Histone Methyltransferase RomA in Infected Cells. ChemBioChem. https://doi.org/10.1002/cbic.202400293
Vancouver
Barbachowska M, Harivel T, Nicchi S, Danckaert A, Ghazarian M, Chiaravalli J, et al. High Content Screening Assay of Inhibitors of the Legionella Pneumophila Histone Methyltransferase RomA in Infected Cells. ChemBioChem. 2024. doi:10.1002/cbic.202400293
BibTeX
@article{Barbachowska2024,
author = {Barbachowska, Magdalena and Harivel, Thomas and Nicchi, Sonia and Danckaert, Anne and Ghazarian, Marine and Chiaravalli, Jeanne and Buchrieser, Carmen and Rolando, Monica and Arimondo, Paola B},
title = {High Content Screening Assay of Inhibitors of the Legionella Pneumophila Histone Methyltransferase RomA in Infected Cells},
journal = {ChemBioChem},
year = {2024},
doi = {10.1002/cbic.202400293}
}
EUVIMED